Health Catalyst Q1 revenue $74.7M, Adj EBITDA $3.4M; beats guidance mid-point

Health Catalyst, Inc.

2024-Q1 EPS reported -$0.35 revenue$74,723,000

Q1 total revenue $74.7M (up 1% YoY), net loss $20.6M (improved 38% from $33.2M loss).
Adjusted EBITDA $3.4M above Q1 guidance range of $2M-$4M.
Reiterates FY2024 revenue guidance $304M-$312M and Adj EBITDA $24M-$26M.
Q2 2024 guidance: revenue $73.5M-$76.5M, Adj EBITDA $5M-$7M.
New platform branded Health Catalyst Ignite; expansion with Saudi German Health announced.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Health Catalyst, Inc. reported the quarter ended March 31, 2024 results: revenue $74.7 million.

Period: the quarter ended March 31, 2024
Revenue: $74.7 million
Result: reported results

Exact text from the filing

today reported financial results for the quarter ended March 31, 2024. “For the first quarter of 2024, I am pleased by our strong financial results, including total revenue of $74.7 million and Adjusted EBITDA of $3.4 million, with these results beating the mid-point of our quarterly guidance on each metric. This financial performance demonstrates our ability to

View on SEC.gov

Browse all earnings releases →

Health Catalyst, Inc. filing history →

Source: SEC EDGAR

accession 0001636422-24-000072

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.